Lovatitan Tablet 5/160 mg

Adult dose

1. Dosing of Valsartan - Essential hypertension: Take 80 mg orally once daily regardless of sex or race. - For patients with difficulty controlling blood pressure, the dose may be increased to a maximum of 320 mg daily. - Elderly patients (75 years or older): Start at 40 mg once daily. - Dose adjustment may be necessary for patients with kidney and liver impairment. - Heart failure: Start with 40 mg orally twice daily, and may increase to 80 mg or 160 mg once per dose.

Child dose

1. Valsartan: Safety and efficacy have not been established in pediatric patients under 18 years of age. 2. Rosuvastatin: No specific dosing mentioned for children.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the 2nd and 3rd trimesters, so discontinuation should be immediate upon confirmation of pregnancy. It should not be used in patients with allergic reactions, severe liver dysfunction, severe kidney failure, or specific genetic diseases. Caution is necessary for elderly patients, patients with high serum potassium levels, and patients with liver impairment while taking this medication, and regular liver function tests are required. If symptoms of muscle pain or weakness occur, consult a doctor immediately, and patients at high risk of muscle damage should be tested for muscle enzymes before and during treatment. This medication may interact with other antihypertensive agents, diuretics, potassium-sparing agents, etc., so be sure to inform the doctor of any medications being taken concurrently. Dizziness may occur when driving or operating machinery, so caution is advised, particularly when starting treatment or changing dosage. This medication can affect liver and kidney function, so regular blood tests and physical exams are necessary. Women of childbearing potential should use appropriate contraception while taking this medication and should consult a doctor if planning pregnancy or if pregnancy is confirmed. Use of this medication during breastfeeding is not recommended; if it must be taken, breastfeeding should be discontinued. In the event of overdose, severe hypotension and altered consciousness may occur, so immediate medical attention is necessary, and treatment should be based on symptoms as there is no specific antidote. This medication should be kept out of reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, difficulty breathing or shortness of breath, asthma attack, respiratory distress associated with cough and fever, jaundice (yellowing of skin or eyes), extreme drowsiness, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

Dyspepsia, nausea, chest discomfort, dizziness, headache, conjunctival hemorrhage, constipation, asthenia, chest pain, facial edema, peripheral edema, nasopharyngitis, urinary tract infection, bruising, increased blood alanine aminotransferase (ALT) and aspartate aminotransferase (AST), elevated creatine phosphokinase, increased potassium levels, elevated gamma-glutamyl transferase, musculoskeletal stiffness, limb pain, sensory loss, anxiety, upper respiratory tract infection, pharyngitis, tonsillitis,

This medication is sensitive to light, so it should be stored in a tightly sealed container that prevents light exposure. Additionally, it is recommended to store it at a temperature between 1 and 30 degrees Celsius.

Appearance

Bright orange oval film-coated tablet

Package unit

56 tablets (14 tablets/PTP x 4)